Highlights of ASH in the Mediterranean
Registration for the 2024 Highlights of ASH in the Mediterranean is now closed. Please register on-site at the meeting on Saturday, March 2.
Highlights of ASH in the Mediterranean
March 2-3, 2024
Conrad Dubai | Dubai, United Arab Emirates
Join the world's leading hematology experts at Highlights of ASH in the Mediterranean, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Through participation in this meeting, you will be able to:
- Recap stand-out abstracts from the most recent ASH annual meeting.
- Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field.
- Participate in interactive panel discussions and attend small group lunch sessions with the experts.
- Improve therapeutic and overall practice methods.
- Discover new treatments for patients.
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
Program Co-Host
ASH is proud to co-host this meeting with the Emirates Society of Haematology.
Program Schedule
The following session topics corresponds to the 2024 Highlights of ASH in the Mediterranean and is subject to change.
| 8:00 a.m. | Registration and Exhibits Open | |
| 8:15 a.m. | Welcome, Introductions, and Announcements | |
| 8:30 a.m. |
Special Education Session: Plasma Cell Dyscrasia Tumor Board |
|
| 9:30 a.m. |
Myeloma & Plasma Cell Dyscrasia |
|
| 10:00 a.m. |
Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia |
|
| 10:30 a.m. |
Panel Discussion |
|
| 11:00 a.m. |
Coffee Break and Exhibits Open |
|
| 11:30 a.m. | Autoimmunity and Complement Disorders Hanny Al-Samkari, MD Harvard University |
|
| 12:00 p.m. |
Nosocomial Hematological Complications |
|
| 12:30 p.m. | Panel Discussion | |
| 1:00 p.m. |
Lunch with the Experts Session (Ticketed Session) & Lunch in the Exhibits Hall |
|
| 2:00 p.m. |
Special Education Session: Hemophilia in Europe, Middle East, and Africa |
|
| 2:30 p.m. | Inherited Bleeding Disorders Angela Weyand, MD University of Michigan |
|
| 3:00 p.m. | Panel Discussion | |
| 3:30 p.m. | Coffee Break and Exhibits Open | |
| 4:00 p.m. | Diagnosis, Management, and Treatment of VTE
Marc Carrier, MD Ottawa Hospital |
|
| 4:30 p.m. | Hemoglobinopathies Kevin Kuo, MD, MSc, FRCPC University Health Network |
|
| 5:00 p.m. | Panel Discussion | |
| 5:30 p.m. | Program Adjourns for the day | |
| 8:00 a.m. | Registration and Exhibits Opens |
| 8:15 a.m. | Welcome and Introductions |
| 8:30 a.m. |
Transfusion Medicine: Blood Banking and Apheresis |
| 9:00 a.m. |
Hematopoietic Stem Cell Transplantation |
| 9:30 a.m. | Panel Discussion |
| 10:00 a.m. | Coffee Break and Exhibition |
| 10:30 a.m. | Acute Lymphoblastic Leukemia John Molina, MD, MEd Cleveland Clinic |
| 11:00 a.m. | Acute Myeloid Leukemia Alison Walker, MD Mayo Clinic |
| 11:30 a.m. | Clonal Hematopoiesis and Myelodysplastic Syndromes Valeria Santini, MD University of Florence |
| 12:00 p.m. | Panel Discussion |
| 12:30 p.m. | Lunch with the Experts Session (Ticketed Session) & Lunch in the Exhibits Hall |
| 1:30 p.m. |
Special Education Session: Lymphoma Tumor Board |
| 2:30 p.m. | Coffee Break and Exhibition |
| 3:00 p.m. |
Low-Grade Lymphoma(Including Chronic Lymphoid Leukemia) |
| 3:30 p.m. |
High-Grade Lymphoma (Including CAR T-cell Therapy) |
| 4:00 p.m. | Special Education Session: CAR T-Cell Therapy & Management of Its Toxicities Oreofe Odejide, MD, MPH Dana-Farber Cancer Institute |
| 4:30 p.m. | Panel Discussion |
| 5:00 p.m. | Closing Remarks and Adjournment |